Molecule Details
| InChIKey | SIFZUZIJSUIQHX-UHFFFAOYSA-N |
|---|---|
| Compound Name | 2,4,5-trichloro-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide |
| Canonical SMILES | O=S(=O)(Nc1cccc(C(F)(F)F)c1)c1cc(Cl)c(Cl)cc1Cl |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 6 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.77 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (6)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P06493 | CDK1 | Homo sapiens | Human | PF00069 | 7.0 | pIC50 | TTD_MultiTarget |
| P14635 | CCNB1 | Homo sapiens | Human | PF02984 PF00134 | 7.0 | IC50 | ChEMBL |
| P24941 | CDK2 | Homo sapiens | Human | PF00069 | 7.0 | pIC50 | TTD_MultiTarget |
| P50613 | CDK7 | Homo sapiens | Human | PF00069 | 6.7 | IC50 | ChEMBL |
| P51946 | CCNH | Homo sapiens | Human | PF16899 PF00134 | 6.7 | IC50 | ChEMBL;BindingDB |
| P90584 | Pfmrk | Plasmodium falciparum | Pathogen | PF00069 | 6.2 | IC50 | ChEMBL;BindingDB |